Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
yttrium-90-ibritumomab 3.2 mg/2 mL Kit 1 Each VIAL (OTHER 72893000704) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 26, 2026 , from http://ppman.hank.ai/transparency/procedure/72893000704/by-state?code_type=OTHER
“yttrium-90-ibritumomab 3.2 mg/2 mL Kit 1 Each VIAL (OTHER 72893000704) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/72893000704/by-state?code_type=OTHER. Accessed
June 26, 2026 .
“yttrium-90-ibritumomab 3.2 mg/2 mL Kit 1 Each VIAL (OTHER 72893000704) by State,” HANK Price Transparency ,
accessed June 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/72893000704/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
72893000704 — Yttrium-90-ibritumomab 3.2 Mg/2 Ml Kit 1 Each Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$93,567
National median
$93,567 – $157,192
IQR (p25 – p75)
22
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$109,384
vs. negotiated
+16.9%
Hospitals reporting
22
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 72893000704 (OTHER), with interquartile range
State Median p25 p75
CA $93,567 $93,567 $157,192
CO $93,567 $93,567 $125,380
FL $93,567 $93,567 $125,380
HI $92,018 $92,018 $92,018